Newsfeed

This area is a possible form of presentation for the integration of news sources relating to listed companies.
The presentation level is a template based on short news services, where users can get a quick overview of the latest news. The detailed views enable further research if interested.

This newsfeed is a compilation of current news from direct connections of TopTier NewsWire services related to listed companies. This feed is for demonstration purposes only. Sector-specific news, public relations and product information can be accessed via the GICS portals > Sector Intelligence section.

US81663L2007
Reset filter
Do you already know our new terminal view? Click here.
FIGI: BBG00XDHY5P9
WGS
GeneDx Holdings Corp
GICS: Health Care · SECTOR: EQTY · SUB-SECTOR: - · THEMEFOLIO: $GRLZ
NAME
GeneDx Holdings Corp
ISIN
US81663L2007
TICKER
WGS
MIC
XNAS
REUTERS
WGS.OQ
BLOOMBERG
WGS US
Wed, 08.07.2026       GeneDx
US81663L2007

NEW YORK, July 7, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025 and May 4, 2026, inclusive (the "Class Period"), of the important August 3, 2026 lead plaint...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Tue, 07.07.2026       GeneDx
US81663L2007

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In GeneDx To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in GeneDx between April 16, 2025 and May 4, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wils...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Tue, 07.07.2026       GeneDx
US81663L2007

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 7, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until August 3, 2026 to file lead plaintiff applications in a securities class action lawsuit against...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Tue, 07.07.2026       GeneDx
US81663L2007

Did you buy WGS securities between April 16, 2025, and May 4, 2026?Affected WGS Investor SummaryWho: GeneDx Holdings Corp. (NASDAQ: WGS)What: Securities fraud class action lawsuit filedClass Period: April 16, 2025 through May 4, 2026Deadline to Seek Lead Plaintiff Status: August 3, 2026Key Lawsuit Allegations: Material misstatements and/or omissio...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Tue, 07.07.2026       GeneDx
US81663L2007

San Diego, California--(Newsfile Corp. - July 7, 2026) - The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of GeneDx Holdings Corp. (NASDAQ: WGS) common stock between April 16, 2025 and May 4, 2026, both dates inclusive (the "Class Period"), have until Monday, August 3, 2026 to seek appointment as lead plaintiff of the...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Tue, 07.07.2026       GeneDx
US81663L2007

LOS ANGELES, July 7, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GeneDx Holdings Corp. ("GeneDx" or "the Company") (NASDAQ: WGS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Tue, 07.07.2026       GeneDx
US81663L2007

LOS ANGELES, July 7, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against GeneDx Holdings Corp. ("GeneDx" or "the Company") (NASDAQ: WGS)  for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholder...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Tue, 07.07.2026       GeneDx
US81663L2007

New York, New York--(Newsfile Corp. - July 6, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025 and May 4, 2026, inclusive (the "Class Period"), of the important August 3, 2026 lead plaintiff deadline.SO WHAT: If you purchased GeneDx commo...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Tue, 07.07.2026       GeneDx
US81663L2007

SAN DIEGO, July 6, 2026 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers of GeneDx Holdings Corp. (NASDAQ: WGS) common stock between April 16, 2025 and May 4, 2026, both dates inclusive (the "Class Period"), have until Monday, August 3, 2026 to seek appointment as lead plaintiff of the GeneDx class action lawsuit. Cap...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Mon, 06.07.2026       GeneDx
US81663L2007

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 6, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until August 3, 2026 to file lead plaintiff applications in a securities class action lawsuit against...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Mon, 06.07.2026       GeneDx
US81663L2007

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In GeneDx To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in GeneDx between April 16, 2025 and May 4, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wils...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Mon, 06.07.2026       GeneDx
US81663L2007

New York, New York--(Newsfile Corp. - July 6, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against GeneDx Holdings Corp. (NASDAQ: WGS) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged violations o...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Sun, 05.07.2026       GeneDx
US81663L2007

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In GeneDx To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in GeneDx between April 16, 2025 and May 4, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wils...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Sat, 04.07.2026       GeneDx
US81663L2007

New York, New York--(Newsfile Corp. - July 3, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025 and May 4, 2026, inclusive (the "Class Period"), of the important August 3, 2026 lead plaintiff deadline.SO WHAT: If you purchased GeneDx commo...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Sat, 04.07.2026       GeneDx
US81663L2007

NEW YORK and NEW ORLEANS, July 3, 2026 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until August 3, 2026 to file lead plaintiff applications in a securities class action lawsuit against GeneDx Holdings Corp. (N...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Fri, 03.07.2026       GeneDx
US81663L2007

New York, New York--(Newsfile Corp. - July 3, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against GeneDx Holdings Corp. (NASDAQ: WGS) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged violations o...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Fri, 03.07.2026       GeneDx
US81663L2007

San Diego, California--(Newsfile Corp. - July 2, 2026) - The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of GeneDx Holdings Corp. (NASDAQ: WGS) common stock between April 16, 2025 and May 4, 2026, both dates inclusive (the "Class Period"), have until Monday, August 3, 2026 to seek appointment as lead plaintiff of the...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Thu, 02.07.2026       GeneDx
US81663L2007

NEW YORK, July 2, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025 and May 4, 2026, inclusive (the "Class Period"), of the important August 3, 2026 lead plaint...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Thu, 02.07.2026       GeneDx
US81663L2007

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 2, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until August 3, 2026 to file lead plaintiff applications in a securities class action lawsuit against...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Thu, 02.07.2026       GeneDx
US81663L2007

NEW YORK, July 2, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against GeneDx Holdings Corp. ("GeneDx" or the "Company") (NASDAQ: WGS).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Thu, 02.07.2026       GeneDx
US81663L2007

Firm is Securitizing Fabric Genomics AcquisitionSAN FRANCISCO, July 2, 2026 /PRNewswire/ -- Hagens Berman (HBSS), a national leader in securities litigation, is actively investigating claims in a securities class action lawsuit against GeneDx Holdings (NASDAQ: WGS) and its executives, alleging defendants misled investors about the Fabric Genomics...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Wed, 01.07.2026       GeneDx
US81663L2007

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 1, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until August 3, 2026 to file lead plaintiff applications in a securities class action lawsuit against...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Wed, 01.07.2026       GeneDx
US81663L2007

Did you buy WGS securities between April 16, 2025, and May 4, 2026?Affected WGS Investor SummaryWho: GeneDx Holdings Corp. (NASDAQ: WGS)What: Securities fraud class action lawsuit filedClass Period: April 16, 2025 through May 4, 2026Deadline to Seek Lead Plaintiff Status: August 3, 2026Key Lawsuit Allegations: Material misstatements and/or omissio...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Wed, 01.07.2026       GeneDx
US81663L2007

New York, New York--(Newsfile Corp. - July 1, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025 and May 4, 2026, inclusive (the "Class Period"), of the important August 3, 2026 lead plaintiff deadline.SO WHAT: If you purchased GeneDx commo...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Wed, 01.07.2026       GeneDx
US81663L2007

Firm is Securitizing Fabric Genomics AcquisitionSan Francisco, California--(Newsfile Corp. - July 1, 2026) - Hagens Berman (HBSS), a national leader in securities litigation, is actively investigating claims in a securities class action lawsuit against GeneDx Holdings (NASDAQ: WGS) and its executives, alleging defendants misled investors about the...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Wed, 01.07.2026       GeneDx
US81663L2007

Important Information Regarding Section 20(a) Individual Liability Claims Against GeneDx CEO and CFO for Alleged $33.42 Per-Share Investor Losses Tied to reimbursement weakness and underperformance of Fabric GenomicsNEW YORK, July 1, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP alerts investors in GeneDx Holdings Corp. (NASDAQ: WGS) that two sen...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Wed, 01.07.2026       GeneDx
US81663L2007

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In GeneDx To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in GeneDx between April 16, 2025 and May 4, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wils...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Tue, 30.06.2026       GeneDx
US81663L2007

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - June 30, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until August 3, 2026 to file lead plaintiff applications in a securities class action lawsuit agains...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Tue, 30.06.2026       GeneDx
US81663L2007

New York, New York--(Newsfile Corp. - June 30, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025 and May 4, 2026, inclusive (the "Class Period"), of the important August 3, 2026 lead plaintiff deadline.SO WHAT: If you purchased GeneDx comm...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Tue, 30.06.2026       GeneDx
US81663L2007

New York, New York--(Newsfile Corp. - June 30, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against GeneDx Holdings Corp. (NASDAQ: WGS) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged violations...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Mon, 29.06.2026       GeneDx
US81663L2007

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - June 29, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until August 3, 2026 to file lead plaintiff applications in a securities class action lawsuit agains...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Mon, 29.06.2026       GeneDx
US81663L2007

Firm is Securitizing Fabric Genomics AcquisitionSAN FRANCISCO, June 29, 2026 /PRNewswire/ -- Hagens Berman (HBSS), a national leader in securities litigation, is actively investigating claims in a securities class action lawsuit against GeneDx Holdings (NASDAQ: WGS) and its executives, alleging defendants misled investors about the Fabric Genomics...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Mon, 29.06.2026       GeneDx
US81663L2007

SAN DIEGO, June 29, 2026 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers of GeneDx Holdings Corp. (NASDAQ: WGS) common stock between April 16, 2025 and May 4, 2026, inclusive (the "Class Period"), have until Monday, August 3, 2026 to seek appointment as lead plaintiff of the GeneDx class action lawsuit. Captioned Bas...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Mon, 29.06.2026       GeneDx
US81663L2007

LOS ANGELES, June 29, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against GeneDx Holdings Corp. ("GeneDx" or "the Company") (NASDAQ: WGS)  for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholde...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Mon, 29.06.2026       GeneDx
US81663L2007

LOS ANGELES, June 29, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GeneDx Holdings Corp. ("GeneDx" or "the Company") (NASDAQ: WGS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U....
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Mon, 29.06.2026       GeneDx
US81663L2007

New York, New York--(Newsfile Corp. - June 28, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025 and May 4, 2026, inclusive (the "Class Period"), of the important August 3, 2026 lead plaintiff deadline.SO WHAT: If you purchased GeneDx comm...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Sun, 28.06.2026       GeneDx
US81663L2007

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In GeneDx To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in GeneDx between April 16, 2025 and May 4, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wils...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Sun, 28.06.2026       GeneDx
US81663L2007

New York, New York--(Newsfile Corp. - June 27, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025 and May 4, 2026, inclusive (the "Class Period"), of the important August 3, 2026 lead plaintiff deadline.SO WHAT: If you purchased GeneDx comm...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Sat, 27.06.2026       GeneDx
US81663L2007

New York, New York--(Newsfile Corp. - June 26, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025 and May 4, 2026, inclusive (the "Class Period"), of the important August 3, 2026 lead plaintiff deadline.SO WHAT: If you purchased GeneDx comm...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Fri, 26.06.2026       GeneDx
US81663L2007

New York, New York--(Newsfile Corp. - June 26, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against GeneDx Holdings Corp. (NASDAQ: WGS) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged violations...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Fri, 26.06.2026       GeneDx
US81663L2007

New York, New York--(Newsfile Corp. - June 25, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025 and May 4, 2026, inclusive (the "Class Period"), of the important August 3, 2026 lead plaintiff deadline.SO WHAT: If you purchased GeneDx comm...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Thu, 25.06.2026       GeneDx
US81663L2007

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - June 25, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until August 3, 2026 to file lead plaintiff applications in a securities class action lawsuit agains...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Thu, 25.06.2026       GeneDx
US81663L2007

Did you buy WGS securities between April 16, 2025, and May 4, 2026?Affected WGS Investor SummaryWho: GeneDx Holdings Corp. (NASDAQ: WGS)What: Securities fraud class action lawsuit filedClass Period: April 16, 2025 through May 4, 2026Deadline to Seek Lead Plaintiff Status: August 3, 2026Key Lawsuit Allegations: Material misstatements and/or omissio...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Thu, 25.06.2026       GeneDx
US81663L2007

SAN FRANCISCO, June 25, 2026 /PRNewswire/ -- GeneDx Holdings (NASDAQ: WGS) faces a securities class action after the price of the company's stock cratered $33.42 (-49%) on May 5, 2026 in response to the company's disastrous Q1 2026 earnings report. The lawsuit seeks to represent investors who purchased shares of GeneDx common stock between April 1...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Thu, 25.06.2026       GeneDx
US81663L2007

SAN DIEGO, June 24, 2026 /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired GeneDx Holdings Corp. (NASDAQ: WGS) common stock between April 16, 2025 and May 4, 2026. GeneDx Holdings Corp is a genomics company that provides genetic testing services for diagnos...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Wed, 24.06.2026       GeneDx
US81663L2007

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - June 24, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until August 3, 2026 to file lead plaintiff applications in a securities class action lawsuit agains...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Wed, 24.06.2026       GeneDx
US81663L2007

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In GeneDx To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in GeneDx between April 16, 2025 and May 4, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wils...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Wed, 24.06.2026       GeneDx
US81663L2007

New York, New York--(Newsfile Corp. - June 24, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against GeneDx Holdings Corp. (NASDAQ: WGS) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged violations...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Tue, 23.06.2026       GeneDx
US81663L2007

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - June 23, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until August 3, 2026 to file lead plaintiff applications in a securities class action lawsuit agains...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Tue, 23.06.2026       GeneDx
US81663L2007

New York, New York--(Newsfile Corp. - June 23, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025 and May 4, 2026, inclusive (the "Class Period"), of the important August 3, 2026 lead plaintiff deadline.SO WHAT: If you purchased GeneDx comm...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink